Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.

Stera S, Balermpas P, Chan MKH, Huttenlocher S, Wurster S, Keller C, Imhoff D, Rades D, Dunst J, Rödel C, Hildebrandt G, Blanck O.

Strahlenther Onkol. 2017 Sep 5. doi: 10.1007/s00066-017-1204-z. [Epub ahead of print]

PMID:
28875297
2.

Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.

Jiang P, Krockenberger K, Vonthein R, Tereszczuk J, Schreiber A, Liebau S, Huttenlocher S, Imhoff D, Balermpas P, Keller C, Dellas K, Baumann R, Rödel C, Hildebrandt G, Jünemann KP, Merseburger AS, Katz A, Ziegler A, Blanck O, Dunst J.

Radiat Oncol. 2017 Aug 18;12(1):138. doi: 10.1186/s13014-017-0872-2.

3.

Dosimetric Implications of Residual Tracking Errors During Robotic SBRT of Liver Metastases.

Chan M, Grehn M, Cremers F, Siebert FA, Wurster S, Huttenlocher S, Dunst J, Hildebrandt G, Schweikard A, Rades D, Ernst F, Blanck O.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):839-848. doi: 10.1016/j.ijrobp.2016.11.041. Epub 2016 Nov 27.

PMID:
28244421
4.

Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.

Andratschke N, Parys A, Stadtfeld S, Wurster S, Huttenlocher S, Imhoff D, Yildirim M, Rades D, Rödel CM, Dunst J, Hildebrandt G, Blanck O.

Radiat Oncol. 2016 May 28;11:74. doi: 10.1186/s13014-016-0652-4.

5.

Number of cerebral lesions predicts freedom from new brain metastases after radiosurgery alone in lung cancer patients.

Rades D, Huttenlocher S, Khoa MT, Thai PV, Hornung D, Schild SE.

Oncol Lett. 2015 Aug;10(2):1109-1112. Epub 2015 Jun 11.

6.

Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis.

Rades D, Huttenlocher S, Šegedin B, Perpar A, Conde AJ, Garcia R, Veninga T, Stalpers LJ, Cacicedo J, Rudat V, Schild SE.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):368-72. doi: 10.1016/j.ijrobp.2015.05.042. Epub 2015 Jun 3.

PMID:
26232852
7.

Impact of stereotactic radiosurgery dose on control of cerebral metastases from renal cell carcinoma.

Rades D, Huttenlocher S, Gebauer N, Hornung D, Trang NT, Khoa MT, Schild SE.

Anticancer Res. 2015 Jun;35(6):3571-4.

PMID:
26026128
8.

A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.

Rades D, Huttenlocher S, Veninga T, Bajrovic A, Bremer M, Rudat V, Schild SE.

Radiat Oncol. 2015 Apr 15;10:90. doi: 10.1186/s13014-015-0403-y.

9.

Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck.

Rades D, Huttenlocher S, Seibold ND, Gebhard MP, Thorns C, Hasselbacher K, Wollenberg B, Schild SE.

BMC Cancer. 2015 Mar 6;15:102. doi: 10.1186/s12885-015-1107-2.

10.

A new tool to predict survival after radiosurgery alone for newly diagnosed cerebral metastases.

Rades D, Huttenlocher S, Dziggel L, Blanck O, Hornung D, Mai KT, Ngo TT, Van Pham T, Schild S.

Asian Pac J Cancer Prev. 2015;16(7):2967-70.

11.

A new instrument for estimating the survival of patients with metastatic epidural spinal cord compression from esophageal cancer.

Rades D, Huttenlocher S, Bajrovic A, Karstens JH, Bartscht T.

Radiol Oncol. 2015 Mar 3;49(1):86-90. doi: 10.2478/raon-2014-0043. eCollection 2015 Mar.

12.

Predicting the survival probability of gastric cancer patients developing metastatic epidural spinal cord compression (MESCC).

Rades D, Huttenlocher S, Bartscht T, Schild SE.

Gastric Cancer. 2015 Oct;18(4):881-4. doi: 10.1007/s10120-015-0458-3. Epub 2015 Jan 15.

PMID:
25588752
13.

Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses.

Rades D, Huttenlocher S, Rudat V, Hornung D, Blanck O, Phuong PC, Khoa MT, Schild SE, Fischer D.

Anticancer Res. 2015 Jan;35(1):333-6.

PMID:
25550568
14.

A new tool predicting survival after radiosurgery alone for one or two cerebral metastases from lung cancer.

Rades D, Huttenlocher S, Dziggel L, Khoa MT, Van Thai P, Hornung D, Schild SE.

Lung. 2015 Apr;193(2):299-302. doi: 10.1007/s00408-014-9676-4. Epub 2014 Dec 21.

PMID:
25528743
15.

Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer.

Rades D, Huttenlocher S, Dahlke M, Hornung D, Blanck O, Van Thai P, Trang NT, Khoa MT, Schild SE.

Anticancer Res. 2014 Dec;34(12):7309-13.

PMID:
25503165
16.

Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer.

Rades D, Huttenlocher S, Hornung D, Blanck O, Schild SE.

BMC Cancer. 2014 Dec 11;14:931. doi: 10.1186/1471-2407-14-931.

17.

Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?

Rades D, Huttenlocher S, Hornung D, Blanck O, Schild SE, Fischer D.

Radiat Oncol. 2014 Dec 4;9:267. doi: 10.1186/s13014-014-0267-6.

18.

Motor function and survival following radiotherapy alone for metastatic epidural spinal cord compression in melanoma patients.

Huttenlocher S, Sehmisch L, Rudat V, Rades D.

J Dermatol. 2014 Dec;41(12):1082-6. doi: 10.1111/1346-8138.12659. Epub 2014 Oct 20.

PMID:
25327333
19.

Identifying melanoma patients with 1-3 brain metastases who may benefit from whole-brain irradiation in addition to radiosurgery.

Huttenlocher S, Sehmisch L, Schild SE, Blank O, Hornung D, Rades D.

Anticancer Res. 2014 Oct;34(10):5589-92.

PMID:
25275060
20.

A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone.

Huttenlocher S, Dziggel L, Hornung D, Blanck O, Schild SE, Rades D.

Radiat Oncol. 2014 Sep 20;9:215. doi: 10.1186/1748-717X-9-215.

Supplemental Content

Loading ...
Support Center